Psilocybin is under clinical development by Silo Pharma and currently in Phase II for Parkinson’s Disease. According to GlobalData, Phase II drugs for Parkinson’s Disease have a 41% phase transition ...
INR:4676. rummy mega slot and fly All patients reached clinical endpoints. Positive results of Phase 2a clinical trial of innovative therapy for Clostridi ...
BetGames TV CDE publishes "Guidelines for the Design of Clinical Trials of Liraglutide Injection Biosimilars" Huiren Pharmaceutical's exclusive new drug Chuanhong Huoxue Capsule has completed the ...